BETADERM Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Betaderm, and what generic alternatives are available?
Betaderm is a drug marketed by Roaco and is included in one NDA.
The generic ingredient in BETADERM is betamethasone valerate. There are sixty-six drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the betamethasone valerate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Betaderm
A generic version of BETADERM was approved as betamethasone valerate by FOUGERA PHARMS INC on August 31st, 1983.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for BETADERM?
- What are the global sales for BETADERM?
- What is Average Wholesale Price for BETADERM?
Summary for BETADERM
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 64 |
| Patent Applications: | 4,827 |
| DailyMed Link: | BETADERM at DailyMed |
US Patents and Regulatory Information for BETADERM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Roaco | BETADERM | betamethasone valerate | CREAM;TOPICAL | 018839-001 | Jun 30, 1983 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
